PPARGC1A and obesity disorder: In healthy men with obesity, 30 days supplementation at 150 mg per day enhanced SIRT1 and PGC-1α protein levels, activated AMPK, decreased circulating glucose and insulin levels, insulin resistance, IL-6, IL-8 and TNF-α concentrations (64).